Gerald E. Hanks
#116,002
Most Influential Person Now
Gerald E. Hanks's AcademicInfluence.com Rankings
Gerald E. Hanksengineering Degrees
Engineering
#3517
World Rank
#4609
Historical Rank
Biomedical Engineering
#171
World Rank
#176
Historical Rank
Gerald E. Hanksphilosophy Degrees
Philosophy
#5041
World Rank
#7749
Historical Rank
Logic
#2383
World Rank
#3366
Historical Rank
Download Badge
Engineering Philosophy
Gerald E. Hanks's Degrees
- PhD Biomedical Engineering Stanford University
- Doctorate Medicine Stanford University
Why Is Gerald E. Hanks Influential?
(Suggest an Edit or Addition)Gerald E. Hanks's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. (1997) (616)
- Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. (2003) (573)
- Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. (2008) (516)
- Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. (1999) (463)
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. (1998) (434)
- Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. (1991) (413)
- Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. (2001) (385)
- Late GI and GU complications in the treatment of prostate cancer. (1997) (364)
- Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. (1991) (348)
- The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. (1993) (323)
- Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. (2000) (283)
- A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. (1999) (273)
- Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. (1991) (259)
- Patterns of care outcome studies results of the national practice in cancer of the cervix (1983) (238)
- The effect of dose on local control of prostate cancer. (1988) (232)
- The patterns of care outcome study for cancer of the uterine cervix results of the second national practice survey (1990) (212)
- Dose response in prostate cancer with 8-12 years' follow-up. (2001) (207)
- Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. (1988) (205)
- Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02. (2008) (202)
- Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31. (2009) (199)
- Diabetes mellitus: a predictor for late radiation morbidity. (1999) (194)
- Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. (2002) (191)
- Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. (1997) (189)
- Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. (1997) (186)
- Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. (1996) (185)
- Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. (1998) (182)
- Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. (1993) (179)
- Hypoxic regions exist in human prostate carcinoma. (1999) (178)
- RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate (2000) (176)
- Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study. (1999) (174)
- What dose of external-beam radiation is high enough for prostate cancer? (2007) (173)
- Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. (1984) (168)
- Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. (1996) (165)
- Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study. (1997) (164)
- Dose selection for prostate cancer patients based on dose comparison and dose response studies. (2000) (162)
- Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. (1992) (162)
- Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. (1991) (160)
- Measurement of intrafractional prostate motion using magnetic resonance imaging. (2002) (156)
- Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02. (2004) (153)
- Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. (2000) (151)
- A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. (1987) (151)
- Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. (1994) (142)
- Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. (1985) (141)
- Tumor and treatment factors improving outcome in stage III-B cervix cancer. (1991) (141)
- Decision-making strategies for patients with localized prostate cancer. (2002) (141)
- Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma. (1994) (140)
- Prostate cancer radiotherapy dose response: an update of the fox chase experience. (2004) (138)
- Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival. (1996) (134)
- Daily CT localization for correcting portal errors in the treatment of prostate cancer. (1998) (130)
- Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. (1995) (129)
- Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. (2005) (129)
- Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. (1995) (128)
- Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age (2000) (128)
- Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06. (1987) (126)
- Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. (1994) (124)
- Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. (1997) (124)
- Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis. (1995) (123)
- Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study (1992) (120)
- Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. (1999) (120)
- Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. (2002) (117)
- Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate--analysis of RTOG study 75-06. (1987) (115)
- Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. (1995) (114)
- Linear regressive analysis using prostate‐specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer (1993) (114)
- Hypoxia in Human Prostate Carcinoma: An Eppendorf Po2 Study (2001) (113)
- Patterns and fate of PSA bouncing following 3D-CRT. (2001) (112)
- Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. (2000) (108)
- Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. (1994) (108)
- COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. (2007) (106)
- MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02. (2009) (105)
- The dissemination of cancer by transurethral resection of locally advanced prostate cancer. (1983) (103)
- Seminoma of the testis: long-term beneficial and deleterious results of radiation. (1992) (103)
- Ultrasound-based stereotactic guidance in prostate cancer--quantification of organ motion and set-up errors in external beam radiation therapy. (2000) (101)
- Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure. (1994) (100)
- Is there an increased risk of second primaries following prostate irradiation? (1998) (99)
- ASTRO 1984 Presidential Address. Optimizing the radiation treatment and outcome of prostate cancer. (1984) (98)
- Radiation inactivation of human prostate cancer cells: the role of apoptosis. (1996) (95)
- Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy (1993) (94)
- 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review. (2000) (94)
- Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy. (2001) (94)
- Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. (2000) (94)
- Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. (1995) (94)
- Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13. (1990) (93)
- NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network. (1996) (93)
- Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. (1997) (92)
- Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time. (1993) (91)
- Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06. (1991) (89)
- Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure. (1992) (88)
- Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02 (2007) (88)
- A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. (1998) (87)
- Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. (2015) (86)
- Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: Patterns of Care Study (PCS). (1995) (86)
- Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505 (1991) (85)
- Patterns of care outcome studies: Results of the national practice in Hodgkin's disease (1983) (84)
- Intra- and interfractional reproducibility of tangential breast fields: a prospective on-line portal imaging study. (1996) (84)
- Practice patterns of palliative care for the United States 1984-1985. (1987) (84)
- Prognostic factors in patients with bladder carcinoma treated with definitive irradiation (1990) (81)
- Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31) (1996) (81)
- An evaluation of setup uncertainties for patients treated to pelvic sites. (1995) (80)
- Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. (2001) (78)
- In vivo Migration of Colony-forming Units from Shielded Bone Marrow in the Irradiated Mouse (1964) (78)
- Obesity and mortality in men with locally advanced prostate cancer (2007) (78)
- Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum (1994) (78)
- The role of external beam radiation therapy after prostatectomy for prostate cancer (1986) (78)
- Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. (2002) (77)
- Palliative radiotherapy for symptomatic adrenal metastases (1990) (77)
- Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior. (1996) (76)
- Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. (2001) (76)
- Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. (1995) (73)
- Recent patterns of growth in radiation therapy facilities in the United States: a patterns of care study report. (1992) (72)
- Validation of a treatment policy for patients with prostate specific antigen failure after three‐dimensional conformal prostate radiation therapy (2003) (72)
- Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma. (1988) (71)
- The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience. (1991) (71)
- Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. (2003) (71)
- NCCN Practice Guidelines for Prostate Cancer. (2000) (69)
- Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility. (1995) (69)
- An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up (2002) (68)
- Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. (2008) (68)
- Conformai external beam treatment of prostate cancer (1997) (67)
- Ten‐year disease free survival after transperineal sonography‐guided iodine‐125 brachytherapy with or without 45‐gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma (1999) (67)
- Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. (1991) (67)
- Patterns of care outcome studies: results of the national practice in seminoma of the testis. (1981) (66)
- Endotoxin protection and colony-forming units. (1967) (62)
- Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate‐specific antigen (PSA), stage, and grade trends in the PSA era (2001) (61)
- Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. (1998) (61)
- Localization of the prostatic apex for radiation treatment planning. (1995) (60)
- Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation. (1994) (59)
- Prostate-specific antigen as a marker of disease activity in prostate cancer. (2002) (59)
- Local recurrence after cystectomy alone for bladder carcinoma (1992) (59)
- PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation. (1994) (58)
- Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology. (2000) (58)
- The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. (1993) (58)
- Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation. (1991) (57)
- Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation. (2001) (56)
- Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. (1999) (56)
- Conservative management of extensive low‐lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy. A report of a phase I‐II trial (1992) (56)
- Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer. (2012) (55)
- Characteristics and quality assurance of a dedicated open 0.23 T MRI for radiation therapy simulation. (2002) (55)
- Surgical complications of intraoperative radiation therapy: The radiation therapy oncology group experience (1992) (55)
- Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. (1996) (54)
- The need for complex technology in radiation oncology. Correlations of facility characteristics and structure with outcome (1985) (54)
- Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202. (2007) (53)
- Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. (1993) (52)
- Treatment planning for primary breast cancer: a patterns of care study. (1996) (52)
- Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. (2008) (51)
- Psychological and Screening Profiles of First-Degree Relatives of Prostate Cancer Patients (2001) (50)
- Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. (1990) (50)
- Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification. (1992) (50)
- Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander. (1993) (49)
- Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02. (2006) (48)
- Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. (2003) (48)
- Age-related prostate cancer metastases. (1998) (48)
- Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. (2003) (47)
- Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer. (1996) (47)
- A comparison of the structure of radiation oncology in the United States and Japan. (1996) (46)
- Conformal radiotherapy for prostate cancer (2000) (46)
- A reappraisal of the international federation of gynecology and obstetrics staging system for cervical cancer. A study of patterns of care (1992) (45)
- The effect of palliative radiation therapy on epidural compression due to metastatic malignant melanoma (1991) (44)
- Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202. (2007) (44)
- Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer. (2000) (44)
- Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate--results of a nationwide overview. (1987) (44)
- The Patterns of Care Outcome Studies: results of the National practice in carcinoma of the larynx. (1984) (44)
- External beam radiation treatment for prostate cancer: still the gold standard. (1992) (43)
- Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy. (1995) (43)
- MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plans. (2002) (43)
- Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer. (2001) (43)
- Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials. (2011) (42)
- Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis. (2007) (42)
- Progress in the treatment of Hodgkin's disease in the United States, 1973 versus 1983. The patterns of care study (1994) (40)
- Radical prostatectomy or radiation therapy for early prostate cancer. Two roads to the same end (1988) (40)
- Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. (1996) (39)
- More on the Uro-Oncology Research Group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate. (1988) (39)
- External beam irradiation of prostate cancer. Conformal treatment techniques and outcomes for the 1990 (1995) (39)
- The 1993-94 patterns of care process survey for breast irradiation after breast-conserving surgery-comparison with the 1992 standard for breast conservation treatment. The Patterns of Care Study, American College of Radiology. (2000) (38)
- Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma. (1991) (38)
- Patterns-of-failure analysis of patients with high pretreatment prostate-specific antigen levels treated by radiation therapy: the need for improved systemic and locoregional treatment. (1996) (38)
- Radiotherapy or surgery for prostate cancer? Ten and fifteen-year results of external beam therapy. (1991) (37)
- The 1989 patterns of care study for prostate cancer: five-year outcomes. (2001) (37)
- Update on the treatment of prostate cancer with external beam irradiation (1998) (36)
- Histopathologic review of prostate biopsies from patients referred to a comprehensive cancer center (1998) (36)
- The structure of radiation oncology in the United States in 1994. (1997) (36)
- The Value of Radiation Therapy as an Adjuvant to Surgery in Intracranial Meningiomas (1986) (36)
- A nondivergent three field matching technique for breast irradiation. (1990) (36)
- Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy : results of sequential nonrandomized phase II studies (1995) (35)
- Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial. (2009) (35)
- The outcome of treatment of 313 patients with T-1 (UICC) prostate cancer treated with external beam irradiation. (1988) (34)
- Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06. (1998) (34)
- Contribution of diagnostic laparotomy to staging non‐Hodgkin's lymphoma (1972) (34)
- Long‐term hormone therapy and radiation is cost‐effective for patients with locally advanced prostate carcinoma (2006) (33)
- Long-term control of prostate cancer with radiation. Past, present, and future. (1996) (33)
- Prostate cancer risk assessment program: a 10-year update of cancer detection. (2007) (33)
- Results of the 1983 patterns of care process survey for definitive breast irradiation. (1991) (32)
- Patterns of radiation treatment of elderly patients with prostate cancer (1994) (32)
- Factors affecting treatment patterns of radiation oncologists in the United States in the palliative treatment of cancer. (1992) (31)
- A comparison of the cost of various treatment methods for early cancer of the prostate. (1986) (31)
- Apparent absence of recovery in endogenous colony-forming cells after irradiation under hypoxic conditions. (1968) (31)
- Treatment systems guidelines for primary rectal cancer from the 1996 Patterns of Care Study. (1998) (30)
- The Patterns of Care Survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas. (2001) (30)
- 2 Conformal technique dose escalation in prostate cancer: improved cancer control with higher doses in patients with pretreatment PSA 10 ngm/ml (1995) (30)
- A preliminary outcome analysis of the Patterns of Care Study in Japan for esophageal cancer patients with special reference to age: non surgery group. (2000) (30)
- Chondrosarcoma of the maxilla: Report of a case responding to super voltage irradiation and review of the literature (1971) (30)
- Patterns of care study of radiation therapy for esophageal cancer in Japan: influence of the stratification of institution on the process. (1998) (30)
- External beam radiation therapy for prostate cancer (2000) (30)
- Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer. (1998) (29)
- The management of cervical lymph node metastasis by megavoltage radiotherapy. (1969) (29)
- Conformal external beam treatment of prostate cancer. (1997) (28)
- The challenge of treating node‐positive prostate cancer. An approach to resolving the questions (1993) (28)
- Megavoltage radiation therapy and lymphangiography in ovarian cancer. (1969) (28)
- Patterns of Care Study Analysis of Outcome Survey Data—Anterior Two‐Thirds of Tongue and Floor of Mouth (1986) (28)
- Summary results from the Facilities Master List surveys conducted by the Patterns of Care Study. (1982) (28)
- Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. (2000) (28)
- Analysis of independent variables affecting survival after recurrence of prostate cancer. (1989) (28)
- Clinical staging of prostate cancer: Reproducibility and clarification of issues (2001) (27)
- Prostate cancer risk assessment program. A model for the early detection of prostate cancer. (1999) (27)
- Patterns of Care Study quantitative evaluation of the quality of radiotherapy in Japan (2002) (27)
- Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer. (1999) (27)
- Computed tomography-magnetic resonance image fusion: a clinical evaluation of an innovative approach for improved tumor localization in primary central nervous system lesions. (1997) (26)
- Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. (2003) (25)
- Conformal radiation in prostate cancer: reduced morbidity with hope of increased local control. (1993) (25)
- Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method. (2002) (25)
- Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process survey. (1998) (25)
- Summary results from the fourth Facilities Master List survey conducted by the Patterns of Care Study. (1983) (25)
- Patterns of Care Outcome Survey: National outcome data for six disease sites* (1982) (24)
- Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation. (1997) (24)
- Analyzing predictive models following definitive radiotherapy for prostate carcinoma (1997) (24)
- Patterns of care survey results: treatment planning for carcinoma of the prostate. (1995) (24)
- NATURAL HISTORY OF LOCALISED PROSTATIC CANCER MANAGED BY CONSERVATIVE THERAPY ALONE (1988) (23)
- The crisis in health care cost in the United States: some implications for radiation oncology. (1992) (23)
- Factors influencing incidence of acute grade ii morbidity in conformal and standard radiation treatment of prostate cancer: univariate and multivariate analysis (1993) (23)
- Local recurrence after cystectomy alone for bladder carcinoma. (1992) (23)
- Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy. (1995) (22)
- Delayed breast abscesses after lumpectomy and radiation therapy. (1990) (22)
- Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control. (2002) (22)
- Intersociety Council on Radiation Oncology essay on the introduction of new medical treatments into practice. (1993) (22)
- Correlation of pre-treatment transurethral resection and prognosis in patients with stage C carcinoma of the prostate treated with definitive radiotherapy--RTOG experience. (1987) (22)
- Failure patterns and hazard rates for failure suggest the cure of prostate cancer by external beam radiation. (2000) (21)
- 95 Phase III trial of adjuvant androgen suppression using goserelin in patients with carcinoma of the prostate treated with definitive radiotherapy (results of RTOG 85-31) (1995) (21)
- Treatment planning for adenocarcinoma of the rectum and sigmoid: a patterns of care study. PCS Committee. (1997) (21)
- Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer. (2004) (21)
- Quality Control and Assurance (1988) (21)
- Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis (2019) (21)
- The relationship of dose to infield failure for stages A, B and C prostate cancer. An analysis of 1516 patients (1987) (20)
- Repopulation of Colony-forming Units in Mice (1967) (20)
- Short communication: CT-MRI image fusion for 3D conformal prostate radiotherapy: use in patients with altered pelvic anatomy. (1996) (20)
- Radical prostatectomy or radiotherapy in carcinoma of prostate. The dilemma continues. (1987) (20)
- 107 Increasing levels of hypoxia in human prostate carcinoma correlate significantly with increasing clinical stage and age: An Eppendorf p02 study (1999) (20)
- Treatment planning for Hodgkin's disease: a patterns of care study. (1995) (20)
- The value of lymphangiography in malignant disease of the uterine cervix. (1972) (20)
- Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group. (1998) (19)
- Prostate cancer: Evaluation and radiotherapeutic management (1992) (19)
- External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States. (1988) (19)
- Comparison of 1 vs 2 or more intracavitary brachytherapy applications in the management of carcinoma of the cervix, with irradiation alone. (1991) (18)
- 22: Ten Year Follow-up of RTOG 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer (2006) (18)
- Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial. (2007) (18)
- The structure of radiation oncology practices in the continental United States. (1988) (18)
- Defining the appropriate dose for prostate cancer patients with PSA<10ng/ml (1998) (17)
- The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer. (1999) (17)
- Treatment planning structure and process in the United States: a "Patterns of Care" study. (1995) (17)
- The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy. (1998) (17)
- Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants. (2003) (17)
- Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies. (1995) (17)
- Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Radiation Therapy Oncology Group. (1991) (16)
- Three-dimensional conformal radiation therapy: what are the costs and benefits? (2000) (16)
- Pretreatment prostate-specific antigen values in patients with prostate cancer: 1989 patterns of care study process survey. (1995) (16)
- Patterns of care outcome studies in Hodgkin's disease: results of the national practice and implications for management. (1982) (15)
- Quality assurance in radiation therapy: clinical and physical aspects. Consensus of best current management: the starting point for clinical quality assessment. (1984) (15)
- Validation of the sexual adjustment questionnaire (SAQ) in prostate cancer patients enrolled on radiation therapy oncology group (RTOG) studies 90-20 and 94-08 (1998) (15)
- Patterns of Care Study of Radiation Therapy for Cervix Cancer in Japan: The Influence of the Stratification of Institution on the Process (1998) (15)
- 1057 Factors related to late GI and GU complications in conformal and conventional radiation treatment of cancer of the prostate (1995) (14)
- A phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies. (1992) (14)
- Improvements observed in care and outcome in carcinoma of the larynx. (1991) (14)
- Positive prostate biopsy laterality and implications for staging. (2003) (14)
- Progress in 3D conformal radiation treatment of prostate cancer. (1999) (14)
- Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials. (2011) (14)
- Prostate Cancer Risk Assessment Program (1999) (14)
- Single-dose and split-dose x-ray studies of the radio-sensitivity of autochthonous radiation-induced lymphosarcomas in C57BL mice. (1965) (13)
- To move or not to move: measurements of prostate motion by urethrography using MRI. (2001) (13)
- Prognostic factors in patients with early stage non-Hodgkin's lymphomas of the head and neck treated with definitive irradiation. (1991) (13)
- Acute mortality and recovery studies in sheep irradiated with cobalt-60 gamma rays or 1-Mvp x-rays. (1966) (13)
- Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy? (1999) (13)
- Results of the 1988-1989 Patterns of Care Study process survey for Hodgkin's disease. (1999) (13)
- A Tissue Biomarker–Based Model That Identifies Patients with a High Risk of Distant Metastasis and Differential Survival by Length of Androgen Deprivation Therapy in RTOG Protocol 92-02 (2014) (13)
- National average for the process of radiation therapy in Japan by Patterns of Care Study. (1999) (13)
- The retrograde urethrogram is more accurate than ct in identifying the caudal prostate margin for conformal treatment planning (1993) (13)
- Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer. (2010) (13)
- Patterns of care study of radiation therapy for cervix cancer in Japan: the influence of the stratification of institution on the process. (2000) (13)
- Conformal external beam treatment of prostate cancer. Commentary (1997) (12)
- A relationship of local prostate dose and subsequent metastasis with 3D CRT in prostate cancer (1998) (12)
- Significance of prone positioning in planning treatment for esophageal cancer. (1991) (12)
- Patterns of care study decision tree and management guidelines for esophageal cancer. American College of Radiology. (1998) (12)
- Variation in the technical support of radiation oncology in different practice settings. (1989) (12)
- Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: A phase II study from radiation therapy oncology group 85-04 (1995) (12)
- Response to 'only 20% of irradiated prostate cancer patients are cured and the remainder may be made worse (1994) (11)
- Failure pattern implications following external beam irradiation of prostate cancer: long-term follow-up and indications of cure. (2000) (11)
- Trends in radiation therapy demographics--1974 to 1983. (1986) (11)
- A hypoxic ratio of prostate pO2/muscle pO2 predicts for biochemical failure in prostate cancer patients (2001) (11)
- Three-dimensional dosimetric comparison of radiation therapy treatment planning of the pancreas. (1992) (11)
- SUPERVOLTAGE RADIATION THERAPY. USE OF THE LINEAR ACCELERATOR FOR TREATING OVARIAN ADENOCARCINOMA. (1965) (11)
- Treatment planning for carcinoma of the cervix: a patterns of care study report. (1996) (11)
- The value of laparotomy in staging lymphomas. (1971) (11)
- Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer. (2004) (10)
- Decreased acute morbidity with conformal static field radiation therapy treatment of early prostate cancer as compared to non-conformal techniques (1991) (10)
- Therapeutic options in the management of incidental carcinoma of the prostate. (1991) (10)
- Picture archiving and communications systems in radiation oncology (PACSRO): tools for a physician-based digital image review system (1995) (10)
- Long term results of treatment of prostate cancer in the USA in 1973, 1978, and 1983 (1992) (10)
- Injury accumulation and recovery in sheep exposed to protracted cobalt-60 gamma radiation. (1966) (10)
- Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy. (1995) (10)
- Practical and technical considerations in establishing an intraoperative radiation therapy program in the community practice. (1988) (10)
- Androgen ablation adjuvant to defintive radiotherapy in carcinoma of the prostate: year 2000 update of RTOG phase III studies 86-10 and 85-31☆ (2000) (9)
- Does age matter in the selection of treatment for men with early‐stage prostate cancer? (2006) (9)
- Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance? (1995) (9)
- Report of the American Society for Therapeutic Radiology and Oncology Working Group on the scope of radiation oncology (SCOPE). (2002) (9)
- The need for subspecialization: intraoperative radiation therapy. (1992) (9)
- 77 Dose escalation in the conformal treatment of prostate cancer: Optimization is made possible by understanding the dose responses for control of cancer and late morbidity (1996) (9)
- Prognostic significance of nodal involvement in locally advanced (stage C) carcinoma of prostate--RTOG experience. (1987) (8)
- Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202. (2013) (8)
- The relationship between facility structure and outcome in cancer of the prostate and uterine cervix. (1991) (8)
- Prostatic specific antigen confirmation of long term cure of prostate cancer treated by external beam radiation in the RTOG (1993) (8)
- Intraoperative radiation therapy: cut bait or keep on fishing? (1996) (8)
- A question-filled future for dose escalation in prostate cancer. (1995) (8)
- Radiotherapeutic management of prostate adenocarcinoma (1999) (8)
- Systematic biopsies: do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone? (1996) (8)
- External beam radiation therapy for prostate cancer clinically confined to the gland. (1989) (8)
- Strategies for improving the outcome of patients with poor prognosis prostate cancers. (1998) (7)
- Radiation therapy as treatment for stage T1c prostate cancers (2005) (7)
- The patterns of care study: a specialty effort to improve care. (1983) (7)
- 1006 bNED control: Praying to a false god? (1997) (7)
- Endometrial cancer with para-aortic adenopathy: Comparison of radiologically and pathologically diagnosed patients (1991) (7)
- Ki-67 staining is a strong predictor of patient outcome for prostate cancer patients treated with androgen deprivation plus radiotherapy: an analysis of RTOG 92–02 (2003) (7)
- Patterns of change in the physics and technical support of radiation therapy in the USA 1975-1986. (1989) (7)
- Quality assurance in radiation oncology in the united states 1988 (1989) (7)
- Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer? (1999) (7)
- PSA doubling times in patients with prostate cancer, a potentially useful reflection of tumor doubling time (1992) (7)
- An overview of the First International Consensus Workshop on Radiation Therapy in the Treatment of Metastatic and Locally Advanced Cancer. (1992) (7)
- Early stage prostate cancer treated with radiation therapy: stratifying an intermediate risk group. (1997) (7)
- Carcinoma of the extrahepatic biliary system- results of primary therapy (1992) (7)
- Cardiovascular Mortality Following Androgen Deprivation Therapy in Men With Locally Advanced Prostate Cancer: An Analysis of RTOG 85-31 (2007) (6)
- Recent patterns of growth in radiation therapy facilities in the United States (1991) (6)
- Apples and oranges in seminoma: a comparison of U.S.A. and Canadian experience. (1983) (6)
- Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. (2019) (6)
- 54 The radiation dose response of the human cervical spinal cord (1999) (6)
- Quality assurance in the EORTC and implications for cooperative studies with the RTOG. (1987) (6)
- Correlates of distant metastasis and death in prostate cancer patients treated with radiotherapy (2002) (6)
- Does screening for prostate cancer make sense? (1996) (6)
- The ASTRO consensus definition of bNED failure is an inappropriate endpoint for prostate cancer patients receiving conformal radiation therapy and androgen deprivation (CRT+AD) (1998) (6)
- 1007 The need for central pathology tumor grading in prostate cancer using radiation therapy oncology group(RTOG) 8531 (1997) (5)
- Treatment of locally advanced prostate cancer with radiation therapy. (1989) (5)
- Surgical therapy for radiation enteritis. (1968) (5)
- Recruitment and altered recovery in noncycling bone marrow stem cells. (1972) (5)
- 44 Long term durability of potency preservation in younger prostate cancer patients following 3D conformal radiation therapy (1999) (5)
- The effects of health care reform on academic medical centers: 1994 Gold Medal Address. (1995) (5)
- The role of adjuvant radiation in the treatment of rectal cancer. (1991) (5)
- Secondary malignant neoplasms in patients with bladder carcinoma. (1992) (5)
- Analysis of bNED control and factors predicting outcome in non-palpable (clinical stage t1c) adenocarcinoma of the prostate treated with 3D conformal external beam radiation therapy (1998) (5)
- 142 Long-term outcome for patients with locally advanced non-metastatic prostate cancer treated with adjuvant hormones and radiation therapy versus radiation therapy alone: Subset analysis of RTOG 85-31 and 86-10 (1999) (5)
- Future plans for quality assurance in radiation oncology in the United States. (1984) (5)
- Does backdating change outcome when the ASTRO definition of biochemical control is used in patients with clinically localized prostate cancer treated with 3D conformal radiation therapy alone (2002) (5)
- Management of esophageal cancer. (1990) (4)
- Should we treat localized prostate cancer? An opinion. (1996) (4)
- Surrogate endpoint for prostate cancer-specific survival: Validation from an analysis of Radiation Therapy Oncology Group Protocol 92–02 (2005) (4)
- The Influence of Age as a Predictor of Outcome in Prostate Cancer Patients Treated on RTOG Trials (2007) (4)
- Evidence for cure of 'young' men with prostate cancer. (2001) (4)
- Lower radiation dose may account for decreased survival of blacks with prosate cancer: Results of the 1978 patterns of care study (1991) (4)
- Spectroscopy in Prostate Cancer: Hope or Hype? (2001) (4)
- Picture archiving and communications systems in radiation oncology (PACSRO): tools for a physician-based digital image review system. (1995) (4)
- A comparison of prostate cancer treatments: are therapeutic implications justified? (1997) (4)
- Validating a treatment policy for PSA failures following 3D-conformal radiation therapy (2000) (4)
- One step forward and two steps back. (1995) (4)
- 1053 Preservation of sexual function in young prostate cancer patients after radiation therapy: A positive factor in choice of a treatment modality (1996) (4)
- Short term androgen deprivation and PSA doubling time: their relationship to one another and to disease progression following radiation therapy for prostate cancer (2002) (4)
- Hypoxia in Human Prostate Carcinoma (2001) (3)
- Abstract of ASTRO proffered papers, posters, and scientific exhibit to be presentedIncidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate (1994) (3)
- Injury accumulation in sheep during protracted gamma radiation. USNRDL-TR-998. (1966) (3)
- Treatment of early stage prostate cancer: radiotherapy. (1994) (3)
- Patterns of Care Study of radiation therapy for uterine cervix cancer in Japan: The influence of age on the process (1999) (3)
- On neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation. (1995) (3)
- Stage II testicular seminoma: evolution of radiotherapeutic practice in the United States. (1990) (3)
- 98 Young patients with prostate cancer have an outcome justifying their acceptance for external beam treatment (1995) (3)
- Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone? (1996) (3)
- Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413 (2015) (3)
- Quality of Treatment: An Overview of the Patterns of Care Study in Clinical Radiation Therapy (1988) (3)
- The adverse effect of turp as method of diagnosis in 494 patients with stage C prostate cancer treated within RTOG protocol 75-06 (1986) (3)
- Patterns of care outcome study: Results of the national practice in Hodgkin's disease (1981) (3)
- Routine use of MRI and CT simulation for treatment planning of intensity modulated radiation therapy (IMRT) in prostate cancer (2001) (3)
- Increasing hypoxia correlates with increased expression of the angiogenesis marker, VEGF in human prostate carcinoma (2000) (3)
- Evaluation of permanent prostate implants: a pilot study comparing dosimetric impact of inter-observer variability using CT and MRI (2001) (3)
- A comparison of daily CT localization to a daily ultrasound based system (BATtm) in prostate carcinoma will bat fly (1998) (3)
- Patterns of care outcome studies: Demonstration of the need for precision in radiation therapy technique (1981) (3)
- The case for external beam treatment of early-stage prostate cancer. (2000) (3)
- Defining the optimal radiation dose with 3D conformal radiation therapy for patients with non-metastatic prostate cancer using recursive partitioning techniques (2000) (3)
- A question-filled future for dose-escalation in prostate cancer--regarding Shipley et al., IJROBP 32:3-12; 1995. (1995) (3)
- Prostate cancer: defining the roles of elective and therapeutic nodal irradiation. (1994) (2)
- A phase I pilot study to evaluate intraoperative radiation therapy (IORT) and the hypoxic cell sensitizer etanidazole (ETA) in patients with locally advanced malignancies (RTOG protocol 89-06) (1992) (2)
- Results of irradiation of a new entity in prostate cancer: Comparison of PSA-failures in TIC vs. other nonpalpable prostate tumors (1994) (2)
- Dose-volume histogram analysis does not completely predict the incidence of late effects of radiation in prostate cancer (2004) (2)
- The Prognostic Value of p16 Expression in Locally Advanced Prostate Cancer: A Study Based on RTOG 92-02 (2005) (2)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee. (2001) (2)
- SURVIVAL ADVANTAGE FOR 3D CRT OF PROSTATE CANCER (1999) (2)
- Who enrolls onto clinical oncology trials? a patterns of care study analysis (2003) (2)
- The Effect of Anoxia on Radiation Injury and Recovery1 (1966) (2)
- International Clinical Trials in Radiation Oncology. Intraoperative trials. (1988) (2)
- 179 Long term quality of life study in prostate cancer patients treated with three dimensional conformal radiation therapy: Bowel and bladder quality of life symptoms are similar to that of the normal population (1999) (2)
- Special requirements for residency training in radiation oncology. Radiation Oncology Subcommittee of the Residency Review Committee for Radiotherapy. (1992) (2)
- Conformal prostate treatment planning without multi-planar computer planning (1992) (2)
- Acute mortality and recovery studies in sheep irradiated with cobalt-60 gamma or 1 Mvp x rays. USNRDL-TR-854. (1965) (2)
- Are only low pretreatment PSA patients curable? Regarding Kuban et al., IJROBP 32:307-316; 1995. (1995) (2)
- Clinical radiobiology of tonsil cancer: A patterns of fractionation study by nine institutions (1994) (2)
- 1067 A comparison of three methods for determining prostate gland volume in anticipation of conformal radiation treatment planning (1995) (2)
- 65 : Temporal Profile of Serum Testosterone With Goserelin Use and Cessation: Analysis of Radiation Therapy Oncology Group Protocol 92-02 (2006) (2)
- Regarding Vicini et al., IJROBP 1999,45:553-561. (2000) (2)
- PSA failure free survival following irradiation for stage T1–T2 prostate cancer patients: The results of an ASTRO sponsored pooled analysis (1998) (2)
- Ultrasound-Based Stereotactic Guidance in Prostate Cancer—Quantification of Organ Motion and Set-Up Errors in External Beam Radiation Therapy (2000) (2)
- 3 Lateral rectal shielding reduces late rectal morbidity after high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a dose effect (1995) (2)
- Injury accumulation and recovery in sheep during protracted gamma irradiation. (1967) (2)
- 116 Initial results of using daily CT localization to correct portal error in prostate cancer (1997) (2)
- Evaluation of significant late morbidity from external beam irradiation for adenocarcinoma of the prostate (Analysis from RTOG Studies 7506 and 7706) (1990) (2)
- Prostate cancer. (1994) (2)
- A comparison of set-up variations using epid devices and film for patients treated for prostate cancer (1993) (2)
- Three dimensional dosimetric comparison of radiation therapy treatment techniques for carcinoma of pancreas (1989) (2)
- Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II endometrial carcinoma (1991) (2)
- 1003 Accounting for competing risks is essential in comparing surgery and radiation treatment of prostate cancer (1997) (2)
- Dancing prostates: measurement of intra-fractional prostate motion using MRI (2001) (1)
- MDM2 Expression Is Independent of P53 and Ki-67 in Predicting Prostate Cancer Outcome: An Analysis of RTOG 92-02 (2005) (1)
- Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities (2018) (1)
- Conformal Static Field Therapy for Low Volume Low Grade Prostate Cancer with Rigid Immobilization: International Journal of Radiation Oncology, Biology, Physics, Vol. 20, January 1991, pp. 141–146 (1991) (1)
- 15 Year USA national averages for patients with seminoma treated with radiation (1991) (1)
- Twenty-five percent positive biopsy rate in a high risk prostate cancer screening program with a PSA ≤ 2.5 ng/ml. (2005) (1)
- RE: The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. (1990) (1)
- Androgen suppression plus radiation therapy for prostate cancer. (2004) (1)
- Use of computerized hot wire block cutter in radiation therapy. (1992) (1)
- 1018 PSA doubling time is an independent predictor for outcome of prostate cancer treated by external beam radiation (1995) (1)
- DNA compaction and radiation-induced cell killing in human prostate cancer cells ASTRO research fellowship (2000) (1)
- Use of transrectal ultrasound to stage prostate cancer. (1994) (1)
- The impact of radiation dose on survival following conformal treatment of prostate cancer (2004) (1)
- 2296 Men treated with radiotherapy have better global quality of life outcomes despite decrements in site-specific quality of life domains than men at increased risk but without prostate cancer (1999) (1)
- Re: Does transurethral resection of the prostate promote metastatic disease? (1988) (1)
- 1124 : Cox-2 Overexpression Predicts Prostate Cancer Outcome: An Analysis of RTOG 92-02 (2006) (1)
- Neutron-photon treatment: modern day Pyrrhic victory? Regarding Haraf et al. IJROBP 33(1): 3-14; 1995. (1996) (1)
- 1127: Socio-Demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-Analysis (2006) (1)
- Superior PSA response in conformal XRT of prostate cancer (1993) (1)
- Predictors of preferences, utilities and quality of life in men treated with 3DCRT for prostate cancer (2002) (1)
- PSA density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy (1994) (1)
- Genitourinary cancer committee (2001) (1)
- 2145 Oral sucralfate reduces the late GI effects of conformal RT for prostate CA: A double-blind placebo-controlled randomized trial (1999) (1)
- Patterns of care study of radiation therapy for esophageal cancer in Japan: influence of age on parameters of treatment (1998) (1)
- A Nondivergent Three Field Matching Technique for Breast Irradiation: International Journal of Radiation Oncology, Biology, Physics, Vol. 19, October 1990, pp. 1037–1040 (1991) (1)
- Does enrollment setting influence patient attributes and outcomes in RTOG prostate cancer trials? (2011) (1)
- Diabetes mellitus: An independent predictor of significant late complications after external-beam radiotherapy (1998) (1)
- Abstract1123: Bcl-2 and Bax Predict Prostate Cancer Outcome in Men Treated With Androgen Deprivation and Radiotherapy on RTOG 92-02 (2006) (1)
- CN3 BEHIND THE VEIL OF IGNORANCE: ASSESSMENT OF PREFERENCES AND UTILITIES FROM MEN AT-RISK FOR PROSTATE CANCER (2002) (1)
- Post treatment biopsies of the prostate: a stalking horse for improving local control. (1992) (1)
- Quantitating regrowth delay of prostate cancers after failure of radiation therapy. (1996) (1)
- 2196: Comparison of Two Types of Biochemical Failures Within the ASTRO and Phoenix Consensus Definitions in Patients Treated on RTOG 92–02 and 94–13 (2006) (1)
- Apples and oranges in the prostate: to TURP or not to TURP? (1988) (1)
- First Annual San Francisco Cancer Symposium November 12–13, 1965 (1966) (1)
- Decreasing Gastrointestinal Morbidity with the Use of Small Bowel Contrast during Treatment Planning for Pelvic Irradiation: International Journal of Radiation Oncology, Biology, and Physics, Vol. 20, April 1991, pp. 835–842 (1992) (1)
- The impact of improved radiotherapy (RT) technique, age and lymph node dissection on the severe complication rate of surgically staged endometrial cancer patients: A multivariate analysis (1992) (1)
- Three dimensional conformal external beam radiation therapy for prostate cancer: The fox chase experience (1998) (1)
- 2280 : Prostate Tumor Biomarker Stability in Archival Tissue From Men Treated With Radiotherapy: An Analysis Of RTOG 92–02 and Fox Chase Randomized Trials (2006) (1)
- 115 Dose escalation with 3-D CRT in prostate cancer: Five year dose responses and optimal treatment (1997) (1)
- 1002 Androgen deprivation does predict bNED survival in unfavorable frostate cancer PTS treated with external beam radiation therapy (1996) (1)
- 2150 Screening with free PSA benefits men at high risk of developing prostate cancer (1999) (1)
- Intratumoral hypoxic cell sensitization with sr2508 in spontaneous feline oral squamous cell carcinoma (1989) (1)
- 2101 Serum PSA profiles after combined androgen deprivation and definitive radiation for localized prostate cancer: Improved biochemical/clinical remission when neoadjuvant androgen deprivation is continued after completion of radiation (1997) (1)
- International comparison of the patterns of care study for esophageal cancer in the United States and Japan: Process survey from 1992 to 1994 (1998) (1)
- A characterization of two commercially available real-time portal imaging systems (1991) (1)
- Proceedings of the 38th Annual ASTRO Meeting139 Androgen suppression plus radiation vs. radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial RTOG 85-31) (1996) (1)
- 68 Impact of target volume coverage with RTOG 98-05 guidelines for transrectal ultrasound guided permanent I-125 prostateimplant (2000) (1)
- The patterns of care study — 1992 (1992) (0)
- Marlex mesh iridium-192 interstitial technique (1984) (0)
- 2133 Intermediate outcomes for 3D-CRT in young men with non-palpable or unilobar prostate cancer and PSA < 20 ng/ml (1999) (0)
- Injury accumulation and recovery in sheep exposed to protracted Co60 gamma radiation. (1967) (0)
- EFFECT OF ANOXIA ON RADIATION INJURY AND RECOVERY. (1969) (0)
- Abstracts of ASTRO proferred papers, posters, and scientific exhibit to be presentedInaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma (1993) (0)
- Post-radiotherapy PSA nadir remains highly predictive of outcome in men who are biochemically free of disease at 1.5 years post-treatment (2003) (0)
- Diagnostic Laparotomy in Non-Hodgkin??s Lymphoma (1971) (0)
- Lymphangiography in Carcinoma of the Cervix (1971) (0)
- The ACR Practice Accreditation Program for radiation oncology. (1990) (0)
- Radiation Therapy for Clinically Localized Prostate Cancer (2016) (0)
- 2295 Quality of life (FACT-C) scores remain at baseline following conformal radiotherapy for prostate cancer: A prospective study (1999) (0)
- In Reply to Drs. Schultz and Kagan (2008) (0)
- HIGH DOSE COMBINATION RADIOTHERAPY FOR THE TREATMENTS OF LOCALIZED PROSTATE CANCER: EDITORIAL COMMENT (1998) (0)
- Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer : Part 1 Review (2017) (0)
- 125 In vitro assays for predicting tumor cell response to radiation by apoptotic pathways (1995) (0)
- The patterns of care study consensus review (1991) (0)
- Surrogate Endpoints for Prostate Cancer Survival: A Secondary Analysis of RTOG 9202 (2007) (0)
- 2128 Need for a national protocol for portal filming practices impacting on target volume dose specification, reporting and delivery (1999) (0)
- Role of External Beam Radiation Therapy in T1/T2 Prostate Cancer (1994) (0)
- 10 The fox chase experience in treating men with three dimensional conformal radiation therapy: Biochemical control, survival and morbidity (2000) (0)
- Apples and Oranges in Seminoma: A Comparison of U.S.A. and Canadian Experience (1984) (0)
- Who is to blame? (1987) (0)
- Re: Simultaneous irradiation for prostate cancer: intermediate results with modern techniques. (2001) (0)
- 1038 How tumor-specific can photodynamic therapy be made? (1995) (0)
- P124 Subjective pathology tumor grading: Impact on design and analysis of radiation therapy oncology group (RTOG) prostate trial 8531 (1997) (0)
- Is adjuvant long-term hormone use necessary when high dose 3D conformal radiation is used in the treatment of locally advanced non-metastatic prostate cancer (2001) (0)
- Equipment and manpower needs in radiation oncology dosimetry and treatment delivery. (1989) (0)
- Treatment planning: Cervix - a patterns of care study report (1993) (0)
- Cancer of the prostate: Clinical decision making and treatment technology (1989) (0)
- The Radiation Therapy Oncology Group: an update of clinical research activities. (1991) (0)
- The Use of Infusional 5-Fluorouracil, Mitomycin C, and Radiation as the Primary Management of Esophageal Cancer (1991) (0)
- Ned survival using strict biochemical criteria in 512 men treated with external beam radiation therapy alone (1994) (0)
- Radiation Oncology in the 1990s (1990) (0)
- Areas of potentially serious age bias in evaluation and treatment of prostate cancer in the usa between 1973–1983 (1993) (0)
- Growth factor expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high dose radiation and chemotherapy (1993) (0)
- Conformal vs conventional technique: A comparison of sequelae-acute symptoms, late complications and cancer control (1996) (0)
- Treatment planning in esophageal cancer — importance of prone positioning (1989) (0)
- 12 RTOG 92-02, RTOG 85-31, and EORTC 22863 indicate the standard of practice for locally advanced and high grade prostate cancer (2000) (0)
- 2052 The correlation of PSA nadir and biochemical freedom from cancer after external beam treatment: Effects of stage, grade and pretreatment PSA groupings (1996) (0)
- Nonrepresentative subsets of patients: Regarding stamey, Ijrobp 33:967–968; 1995 (1995) (0)
- Contents, Vol. 22, 1968 (1968) (0)
- Diabetes and mortality in men with locally advanced prostate cancer: analyses of RTOG 92–02 (2008) (0)
- Closing comments and future international cooperation (1984) (0)
- Influence of stage, grade, and age on overall survival in prostate cancer patients treated with radiation: Results from a nationwide database (1998) (0)
- PCN1: CATEGORIZATION OF RISK OF PROSTATE CANCER: PILOT TEST OF CLINICAL OUTCOMES AND RISK PERCEPTIONS (2001) (0)
- 1456: Recursive Partitioning Analysis of Predictors of Distant Metastasis for Men with Prostate Cancer Treated with Radiotherapy and Androgen Deprivation on RTOG 9202: The Impact of KI-67 (2004) (0)
- Prostate screening programs hosted by radiation oncologists: Feasibility and outcome (1995) (0)
- In Reply to Drs. Cheung and Schulz and Kagan (2008) (0)
- COLONY-FORMING UNIT REPOPULATION AND SPLIT-DOSE RADIOSENSITIVITY IN ENDOTOXIN TREATED AND CONTROL LAF1 MICE (1966) (0)
- 2131 Factors predictive of outcome in 233 patients with gleason score 7 prostate cancer treated with three dimensional conformal external beam radiation therapy (1999) (0)
- Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer : Part 2 (2017) (0)
- Comparison of three methods for determining prostate gland volume in anticipation of conformal radiation treatment planning (1996) (0)
- COMMENT ON DOSE ESCALATION AND BIOCHEMICAL FAILURE IN PROSTATE CANCER : IN REGARD TO KUBAN ET AL. (INT J RADIA T ONCOL BIOL PHYS 2008;70:67-74). Authors' reply (2008) (0)
- Outcome of radiation therapy as primary treatment of breast cancer in a community hospital (1984) (0)
- NONREPRESENTATIVE SUBSETS OF PATIENTS (1995) (0)
- Evaluation of the patient with lymphoma including diagnostic laparotomy. (1970) (0)
- Decreased acute morbidity from evolving 3D conformal radiation therapy technique (2000) (0)
- Body mass index and mortality in men treated for locally advanced prostate cancer: An analysis of RTOG 85–31 (2007) (0)
- Prostate-specific antigen as a marker of disease activity in prostate cancer. (2002) (0)
- Where is radiotherapy for stage C prostate cancer headed? (1994) (0)
- Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group (RTOG) prostate clinical trials. (2009) (0)
- Abstracts of ASTRO scientific papers to be presentedLong term results of treatment of cervix cancer in the USA in 1973, 1978, and 1983 (1993) (0)
- Age: Does it matter in the selection of treatment for men with early-stage prostate cancer? (2006) (0)
- Socioeconomic factors in patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992–1994 patterns of care survey (1998) (0)
- The radiation sensitivity of mitotically inactive mouse bone-marrow stem cells. Abstr. (1968) (0)
- Colony-forming unit repopulation and control split-dose radiosensitivity in endotoxin treated and LAF1 mice. USNRDL-TR-1024. (1966) (0)
- The outcome of 354 patients treated for T-1, N-OX, M-0 prostate cancer in the united states (1986) (0)
- Trailer-park radiology. (1969) (0)
- 2143 Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer (1999) (0)
- The patterns of care study - 1993 (1993) (0)
- ABSENCE OF THE SYNERGISTIC EFFECT OF WHOLE-BODY IRRADIATION AND LOCAL TUMOUR IRRADIATION IN AN AUTOCHTHONOUS LYMPHOID TUMOUR SYSTEM. (1964) (0)
- Ten year outcome analysis of 682 patients treated for prostate cancer with radiation therapy in the United States (1984) (0)
- Counseling the Patient on Choice of Therapy and Outcomes (2000) (0)
- The radiation therapy oncology group: An update of clinical research activities (1991) (0)
- Personalized Medicine and Imaging A Tissue Biomarker – Based Model That Identi fi es Patients with a High Risk of Distant Metastasis and Differential Survival by Length of AndrogenDeprivation Therapy in RTOG Protocol 92-02 (2014) (0)
- AWARD NUMBER: DAMD17-01-1-0006 TITLE: Facilitating Treatment Decision Making, Adjustment, and Coping in Men Newly Diagnosed with Prostate Cancer (2006) (0)
- 2020 TRUS and MRI should not be used to stage patients with prostate cancer: An outcome based analysis (1995) (0)
- Clinical implications of the patterns of care study in cervix cancer (1980) (0)
- Altered recovery in non-cycling bone marrow stem cells (1973) (0)
- Model-based prediction of biochemical failure in prostate cancer patients following radiation therapy (2002) (0)
- Evaluation and treatment of patients receiving radiation for cancer of the rectum or sigmoid colon in the united states: Results of the 1989 patterns of care study process survey (1993) (0)
- 1010 Post treatment PSA nadirs support continuing dose escalation study in patients with pretreatment PSA levels >10 ng/ml, but not in those with PSA <10 ng/ml (1996) (0)
- The use of prostate biopsy laterality results in localized prostate cancer does not predict for 7-yr bNED outcome (2002) (0)
- Post-Treatment PSA Nadir as an Independent Predictor of Distant Metastasis Following Radiotherapy for Prostate Cancer: 10:29 AM (29) (2002) (0)
- Digital imaging in the radiation oncology environment: A personal computer local area network solution (1991) (0)
- Relative survival rates applied to cancer trials (1985) (0)
- ENDOTOXIN-PROTECTION OF MICE. THE RELATIONSHIP TO COLONY-FORMING UNITS (1965) (0)
- The structure of iort in the united states, and clinical trials of its efficacy in RTOG (1987) (0)
- Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials (2015) (0)
- The relationship between prostate volume, PSA nadir, and biochemical control (2001) (0)
- Problems in the 1997 AJCC staging system for prostate carcinoma (1998) (0)
- Apparent absence of recovery in endogenous colony-forming cells after irradiation under hypoxic conditions. USNRDL-TR-1086. (1967) (0)
- Radiation therapists manpower needs potentially affected by recent trends in education and health care management (1996) (0)
- Randomized study to evaluate efficacy of levamisole in patients with unresectable non-oat cell carcinoma of the lung treated with radiation therapy (1984) (0)
- 64 Radiation therapy for rectosigmoid and rectal cancer: Results of the 1996 patterns of care (PCS) process survey for patients treated in 1992–1994 (1997) (0)
- Radiation dose requirements for favorable risk prostate cancer subgroups using recursive partitioning (2002) (0)
- Serum PSA profiles after discontinuation of androgen deprivation (AD) therapy in clinically localized prostate cancer patients treated with definitive conformal radiation (CRT) (2000) (0)
- Response to editorial by Zelefsky et al. (1993) (0)
- Pretreatment serum prostate‐specific antigen (PSA) level and PSA doubling times (PSADT) in black and white men with prostate cancer referred for radiation therapy (1996) (0)
- 1011 Evidence for increased failure in patients with perineural invasion treated with three-dimensional conformal radiation therapy (1996) (0)
- In response to Drs. Ben-Josef and Kaza (1996) (0)
- Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer : Part 2 Review (2017) (0)
- 2092 Is it necessary to irradiate the entire seminal vesicles in patients at risk for seminal vesicle invasion (1997) (0)
- Late GI and GU morbidity profiles in prostate cancer patients treated with 3D-CRT to 81-84 Gy by a 4-field beam arrangement (2001) (0)
- 119 : Predictors of Late Toxicities and Symptom Clusters in Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials of High Risk Patients: A Meta-Analysis of Physician Rated Toxicities (2006) (0)
- Practice type & race influence enrollment onto clinical oncology trials: A Patterns of Care Study analysis. (2004) (0)
- Single and fractionated tumoricidal x-ray dose studies on induced mouse lymphosarcomas. Abstr. (1962) (0)
- 66 IMPACT OF ULTRAHIGH BASELINE PSA LEVELS ON BIOCHEMICAL AND CLINICAL OUTCOMES IN TWO RADIATION THERAPY ONCOLOGY GROUP (RTOG) PROSTATE CANCER (PC) CLINICAL TRIALS (2009) (0)
- Physical aspects of quality assurance. The Committee on Quality Assurance in Radiation Oncology. (1990) (0)
- 2094 Is there a subset of patients with PSA ≥ 20 ng/ml who do well after conformal beam radiotherapy? (1997) (0)
- Gender as a Determinant of Palliative Radiotherapy: A Patterns-of-Care-Study Analysis (1994) (0)
- Gleason score 4 + 3 prostate cancer patients have worse outcome compared to gleason score 3 + 4 treated with radiation therapy alone: Subset analysis of RTOG 85-31 and 86-10 (2000) (0)
- The 1989 acr patterns of care study for prostate cancer: Five year results in the PSA era (1998) (0)
- Patterns of care studies in III-B cervix cancer: Tumor and treatment factors improving outcome (1990) (0)
- Simon Kramer, M.D. (1991) (0)
- Absence of recovery in endogenous colony forming cells following irradiation under hypoxic conditions. Abstr. (1966) (0)
- 2107 International comparison of the patterns of care study for esophageal cancer in the United States and Japan: Process survey from 1992 to 1994 with special reference to age (1999) (0)
- COMMENTARY ON DOSE ESCALATION AND BIOCHEMICAL FAILURE IN PROSTATE CANCER : IN REGARD TO EADE ETAL. Authors' reply (2008) (0)
- Hodgkin's disease: successful dissemination of high technology treatment throughout the United States. (1985) (0)
- Diabetes and Cardiovascular Mortality in Men With Locally Advanced Prostate Cancer: Updated Analysis From RTOG 92-02 (2012) (0)
- Outcome analysis of prostate cancer patients treated with observation (2002) (0)
- 2238 The patterns of care study in Japan: A preliminary analysis of process survey from 1995 to 1997 (1999) (0)
- 198 Dose response functions for favorable and unfavorable subgroups of the classic pretreatment PSA groups (1999) (0)
- Use of computerized hot wire block cutter in radiation therapy (1990) (0)
- Highly predictive biochemical indicators of distant metastasis and death due to prostate cancer (2001) (0)
- Prognosis in Lymphadenectomy Evaluated Stage A2 and B Carcinoma of the Prostate Treated with Curative Radiotherapy – Results of a Nationwide Survey (1987) (0)
- Modeling post-radiation PSA level kinetics: Predictors of rising post-nadir slope suggest cure in men who remain biochemically free of prostate cancer (1998) (0)
- Abstracts of ASTRO proffered to be presentedVolumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander (1992) (0)
- 2100 Radiation morbidity in postprostatectomy patients treated definitively (1997) (0)
- In response to Dr. Anderson (1995) (0)
- Radiation Dose Escalation Reduces Distant Metastasis and Increases Survival for Men with Prostate Cancer: 10:22 PM (28) (2002) (0)
- Proceedings of the 36th annual ASTRO meetingCarcinoma of the cervix patterns of care studies. Review of 1978,1983,1988-89 surveys (1994) (0)
- Title Duration of Androgen Deprivation in Locally Advanced Prostate Cancer : Long-Term (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gerald E. Hanks?
Gerald E. Hanks is affiliated with the following schools:
